Quick Answer
AVENUE THERAPEUTICS, INC. reported Cash and Equivalents of $2.85 million for fiscal year 2025.
AVENUE THERAPEUTICS, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $2.85M | +10.1% |
| 2024 | $2.59M | +45.5% |
| 2023 | $1.78M | -73.4% |
| 2022 | $6.71M | +78.3% |
| 2021 | $3.76M | +20.1% |
| 2020 | $3.13M | -64.2% |
| 2019 | $8.74M | +227.4% |
| 2018 | $2.67M | -77.3% |
| 2017 | $11.78M | +5880.7% |
| 2016 | $197.0K | +1307.1% |
| 2015 | $14.0K | — |
| 2015 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.71M | +42.8% | +11.5% |
| June 30, 2025 | $3.33M | -32.4% | -5.0% |
| March 31, 2025 | $3.50M | +9.6% | +35.0% |
| December 31, 2024 | $2.59M | +45.5% | -0.1% |
| September 30, 2024 | $2.60M | +1513.0% | -47.2% |
| June 30, 2024 | $4.92M | +213.1% | +54.0% |
| March 31, 2024 | $3.19M | -61.2% | +79.1% |
| December 31, 2023 | $1.78M | -73.4% | +1007.5% |
- AVENUE THERAPEUTICS, INC. showed an increase of +10.1% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from AVENUE THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: